SuperGen, Inc. Reports 2009 Fourth Quarter and Year-End Financial Results

DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen Inc., (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today reported financial results for the fourth quarter and year ended December 31, 2009.